This country profile provides an overview of Gambia’s progress in reaching those in need of mass NTD treatment based on 2017 data.
*This includes all countries in Africa that are endemic for at least one of the five NTDs
Download country profile
Priorities for progress in Gambia
- Gambia is encouraged to work to build a strong preventive chemotherapy programme for bilharzia and intestinal worms, with systematic annual high-coverage implementation of all components, in all risk groups, as recommended by WHO.
- Support the Expanded Special Project for Elimination of Neglected Tropical Diseases (ESPEN) established by WHO AFRO region for the elimination of these five diseases.
Gambia does not require mass treatment for elephantiasis.
Gambia does not require mass treatment for blinding trachoma.
Treatment coverage decreased from 47% in 2016 to 44% in 2017.
Treatment coverage was not reported in 2016 and 85% in 2017.
Gambia does not require mass treatment for river blindness.
The ESPEN portal (a World Health Organization AFRO region project) provides maps and district-level data for the preventive chemotherapy diseases in the Gambia.